✦ LIBER ✦

Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate

✍ Scribed by U. Gessner; D. Koeberle; B. Thuerlimann; L. Bacchus; B. Horisberger

Publisher: Springer-Verlag
Year: 2000
Tongue: English
Weight: 105 KB
Volume: 8
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200050025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pamidronate treatment in patients with m

Pamidronate treatment in patients with malignant osteolytic bone disease and pain

✍ D. Koeberle; L. Bacchus; B. Thuerlimann; H.-J. Senn 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 75 KB

Pamidronate for pain control in patients

Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study

✍ B. Thürlimann; R. Morant; W. F. Jungi; A. Radziwill 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 495 KB

In a prospective dose-escalation study tolerability and effectiveness of repeated infusions with intravenous pamidronate were investigated. A total of 80 patients with proven malignancy and pain due to osteolytic bone disease were enrolled. Doses of 30 mg, 45 mg, 60 mg and 90 mg pamidronate, given e